• Users Online: 86
  • Print this page
  • Email this page

October-December 2019| Vol 6| Issue 4

Review Article

Future of 5-fluorouracil in cancer therapeutics, current pharmacokinetics issues and a way forward

Background: In addition to exhibiting antitumor potential, antitumor drugs exhibit toxicity due to a poor pharmacokinetic profile. An enormous amount of research has been carried out and is s...


Review Article

Thyroid hormone, PD-L1, and cancer

Objective: Thyroid hormone plays a vital role in maintaining whole-body physiological activities. However, several different disorders can arise when thyroid hormone is abnormal. Even more, t...


Original Article

Neutrophil lymphocyte ratio is an independent prognosticator in patients with locally advanced head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

Background: The aim of the present study was to evaluate the prognostic value of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in patients with locally advanced head a...


Original Article

Association between serum folate level and invasive cervical cancer at a university teaching hospital in South-West Nigeria

Background: Cervical cancer is a common cause of cancer-related morbidity and mortality in developing countries. Serum folate may modify cancer risk through its role in DNA synthesis and meth...


Case Report

Identification of docetaxel, cisplatin, and 5-fluorouracil regimen hypersensitivity by In vitro T-cell activation assay

An in vitro T-cell activation assay measuring granulysin and granzyme B has been used to identify the drug hypersensitivity of common causative drugs, but not of chemotherapeutic drugs. Both ...


View All Articles in the Current Issue
Cover page Image

Journal of Cancer Research and Practice, a publication of Taiwan Oncology Society, is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN center , ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ